HEADER ISOMERASE/ISOMERASE INHIBITOR 06-JUN-14 4TOT TITLE CRYSTAL STRUCTURE OF RAT CYCLOPHILIN D IN COMPLEX WITH A POTENT TITLE 2 NONIMMUNOSUPPRESSIVE INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: PEPTIDYL-PROLYL CIS-TRANS ISOMERASE F, MITOCHONDRIAL; COMPND 3 CHAIN: A, B, C, D; COMPND 4 FRAGMENT: UNP RESIDUES 43-206; COMPND 5 SYNONYM: PPIASE F,CYCLOPHILIN D,CYPD,CYCLOPHILIN F,ROTAMASE F; COMPND 6 EC: 5.2.1.8; COMPND 7 ENGINEERED: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: NONIMMUNOSUPPRESSIVE INHIBITOR; COMPND 10 CHAIN: E, F, G, H; COMPND 11 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: RATTUS NORVEGICUS; SOURCE 3 ORGANISM_COMMON: RAT; SOURCE 4 ORGANISM_TAXID: 10116; SOURCE 5 GENE: PPIF; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 MOL_ID: 2; SOURCE 10 SYNTHETIC: YES; SOURCE 11 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 12 ORGANISM_TAXID: 32630 KEYWDS INHIBITOR, COMPLEX, CYCLOSPORIN, ISOMERASE-ISOMERASE INHIBITOR KEYWDS 2 COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR M.S.KNAPP,R.A.ELLING REVDAT 3 03-APR-24 4TOT 1 REMARK REVDAT 2 27-DEC-23 4TOT 1 SOURCE JRNL REMARK DBREF REVDAT 2 2 1 LINK REVDAT 1 12-NOV-14 4TOT 0 JRNL AUTH J.FU,M.TJANDRA,C.BECKER,D.BEDNARCZYK,M.CAPPARELLI,R.ELLING, JRNL AUTH 2 I.HANNA,R.FUJIMOTO,M.FUREGATI,S.KARUR,T.KASPRZYK,M.KNAPP, JRNL AUTH 3 K.LEUNG,X.LI,P.LU,W.MERGO,C.MIAULT,S.NG,D.PARKER,Y.PENG, JRNL AUTH 4 S.ROGGO,A.RIVKIN,R.L.SIMMONS,M.WANG,B.WIEDMANN,A.H.WEISS, JRNL AUTH 5 L.XIAO,L.XIE,W.XU,A.YIFRU,S.YANG,B.ZHOU,Z.K.SWEENEY JRNL TITL POTENT NONIMMUNOSUPPRESSIVE CYCLOPHILIN INHIBITORS WITH JRNL TITL 2 IMPROVED PHARMACEUTICAL PROPERTIES AND DECREASED TRANSPORTER JRNL TITL 3 INHIBITION. JRNL REF J.MED.CHEM. V. 57 8503 2014 JRNL REFN ISSN 0022-2623 JRNL PMID 25310383 JRNL DOI 10.1021/JM500862R REMARK 2 REMARK 2 RESOLUTION. 2.39 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.4 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.39 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.30 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 90.9 REMARK 3 NUMBER OF REFLECTIONS : 29998 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.198 REMARK 3 R VALUE (WORKING SET) : 0.196 REMARK 3 FREE R VALUE : 0.230 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.060 REMARK 3 FREE R VALUE TEST SET COUNT : 1517 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 15 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.39 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.47 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 90.94 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2071 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2229 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1973 REMARK 3 BIN R VALUE (WORKING SET) : 0.2190 REMARK 3 BIN FREE R VALUE : 0.3013 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.73 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 98 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5324 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 86 REMARK 3 SOLVENT ATOMS : 298 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 33.71 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 19.55 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.11150 REMARK 3 B22 (A**2) : -2.03810 REMARK 3 B33 (A**2) : 2.14960 REMARK 3 B12 (A**2) : -0.40180 REMARK 3 B13 (A**2) : 1.26940 REMARK 3 B23 (A**2) : -0.93740 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.300 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.416 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.241 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.540 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.247 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.901 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.868 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 6168 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 8900 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 2096 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 116 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 808 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 6168 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 708 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : 8 ; 1.000 ; HARMONIC REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 7267 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : 1.10 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.83 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 14.98 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 5 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|2 - A|165 } REMARK 3 ORIGIN FOR THE GROUP (A): -13.0320 -16.0969 2.5827 REMARK 3 T TENSOR REMARK 3 T11: 0.0492 T22: -0.1202 REMARK 3 T33: -0.0756 T12: 0.0066 REMARK 3 T13: -0.0329 T23: -0.0184 REMARK 3 L TENSOR REMARK 3 L11: 0.4244 L22: 1.1893 REMARK 3 L33: 0.8602 L12: 0.2657 REMARK 3 L13: 0.0024 L23: 0.0551 REMARK 3 S TENSOR REMARK 3 S11: -0.0014 S12: 0.0251 S13: -0.0311 REMARK 3 S21: -0.0447 S22: 0.0430 S23: -0.0943 REMARK 3 S31: 0.0018 S32: 0.0885 S33: -0.0415 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: { B|2 - B|165 } REMARK 3 ORIGIN FOR THE GROUP (A): -18.2692 12.5836 19.8755 REMARK 3 T TENSOR REMARK 3 T11: 0.0539 T22: -0.1063 REMARK 3 T33: -0.0892 T12: 0.0071 REMARK 3 T13: -0.0382 T23: 0.0046 REMARK 3 L TENSOR REMARK 3 L11: 0.2042 L22: 1.4303 REMARK 3 L33: 1.0433 L12: -0.1741 REMARK 3 L13: -0.0216 L23: -0.0255 REMARK 3 S TENSOR REMARK 3 S11: -0.0234 S12: -0.0294 S13: -0.0421 REMARK 3 S21: 0.0354 S22: 0.0298 S23: 0.1141 REMARK 3 S31: -0.0105 S32: -0.0522 S33: -0.0064 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 SELECTION: { C|2 - C|165 } REMARK 3 ORIGIN FOR THE GROUP (A): -27.7173 -17.3557 47.0278 REMARK 3 T TENSOR REMARK 3 T11: 0.0349 T22: -0.0807 REMARK 3 T33: -0.1075 T12: -0.0002 REMARK 3 T13: -0.0416 T23: 0.0047 REMARK 3 L TENSOR REMARK 3 L11: 0.7568 L22: 1.4661 REMARK 3 L33: 0.6272 L12: 0.1275 REMARK 3 L13: 0.6169 L23: 0.4515 REMARK 3 S TENSOR REMARK 3 S11: -0.0042 S12: 0.1899 S13: 0.0286 REMARK 3 S21: -0.0607 S22: 0.0545 S23: -0.0207 REMARK 3 S31: -0.0363 S32: 0.1566 S33: -0.0502 REMARK 3 REMARK 3 TLS GROUP : 4 REMARK 3 SELECTION: { D|2 - D|165 } REMARK 3 ORIGIN FOR THE GROUP (A): 4.6106 11.3164 50.2134 REMARK 3 T TENSOR REMARK 3 T11: 0.0489 T22: -0.0819 REMARK 3 T33: -0.0949 T12: 0.0227 REMARK 3 T13: -0.0434 T23: -0.0061 REMARK 3 L TENSOR REMARK 3 L11: 0.8004 L22: 0.5828 REMARK 3 L33: 0.9933 L12: -0.0044 REMARK 3 L13: 0.5141 L23: -0.3317 REMARK 3 S TENSOR REMARK 3 S11: -0.0043 S12: -0.1978 S13: -0.0210 REMARK 3 S21: 0.0710 S22: 0.0870 S23: -0.0308 REMARK 3 S31: -0.0544 S32: -0.1852 S33: -0.0827 REMARK 3 REMARK 3 TLS GROUP : 5 REMARK 3 SELECTION: { A|201 - A|202 C|201 - C|201 B|201 - B|202 E|1 - REMARK 3 E|11 D|201 - D|201 G|1 - G|11 F|1 - F|11 H|1 - H|11 } REMARK 3 ORIGIN FOR THE GROUP (A): -13.6036 -2.4039 29.6640 REMARK 3 T TENSOR REMARK 3 T11: 0.0908 T22: -0.1155 REMARK 3 T33: -0.0798 T12: 0.0277 REMARK 3 T13: -0.0232 T23: -0.0104 REMARK 3 L TENSOR REMARK 3 L11: 0.0384 L22: 0.1222 REMARK 3 L33: -0.0226 L12: 0.1528 REMARK 3 L13: 0.1028 L23: -0.1634 REMARK 3 S TENSOR REMARK 3 S11: 0.0042 S12: 0.0127 S13: -0.0085 REMARK 3 S21: 0.0711 S22: -0.0085 S23: 0.0529 REMARK 3 S31: 0.0073 S32: -0.0486 S33: 0.0043 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4TOT COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 11-AUG-14. REMARK 100 THE DEPOSITION ID IS D_1000201853. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 28-SEP-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E+ SUPERBRIGHT REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : BRUKER PLATINUM 135 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 30008 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.390 REMARK 200 RESOLUTION RANGE LOW (A) : 45.470 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 90.9 REMARK 200 DATA REDUNDANCY : 3.220 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.8200 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: IN-HOUSE STRUCTURE REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 59.55 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.04 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM MES PH 6.5, 5% (V/V) PEG 400, REMARK 280 2M AMMONIUM SULFATE, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 291.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1450 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 7790 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -16.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1480 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 7860 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -18.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1380 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 7760 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -9.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, G REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1360 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 7700 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -9.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: D, H REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 REMARK 400 THE NONIMMUNOSUPPRESSIVE INHIBITOR IS CYCLIC PEPTIDE, A MEMBER OF REMARK 400 INHIBITOR CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: NONIMMUNOSUPPRESSIVE INHIBITOR REMARK 400 CHAIN: E, F, G, H REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: NULL REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 1 REMARK 465 ALA B 1 REMARK 465 ALA C 1 REMARK 465 ALA D 1 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 148 CG CD CE NZ REMARK 470 LYS D 148 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 60 -76.46 -146.04 REMARK 500 THR A 119 50.29 -99.39 REMARK 500 PHE B 60 -78.96 -146.03 REMARK 500 ASN B 71 12.45 -143.45 REMARK 500 THR B 119 50.32 -99.37 REMARK 500 PHE C 60 -78.26 -145.67 REMARK 500 THR C 119 50.35 -99.81 REMARK 500 PHE D 60 -79.46 -145.70 REMARK 500 ASN D 71 -1.23 -143.89 REMARK 500 THR D 119 50.51 -99.95 REMARK 500 MVA E 4 73.91 -117.72 REMARK 500 MVA F 4 76.43 -119.44 REMARK 500 MVA G 4 74.93 -110.36 REMARK 500 MVA H 4 74.74 -112.00 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 376 DISTANCE = 7.28 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue P6G A 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 A 202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue P6G B 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue SO4 B 202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue P6G C 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue P6G D 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for nonimmunosuppressive inhibitor REMARK 800 chain E REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for nonimmunosuppressive inhibitor REMARK 800 chain F REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for nonimmunosuppressive inhibitor REMARK 800 chain G REMARK 800 REMARK 800 SITE_IDENTIFIER: AD1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for nonimmunosuppressive inhibitor REMARK 800 chain H DBREF 4TOT A 2 165 UNP P29117 PPIF_RAT 43 206 DBREF 4TOT B 2 165 UNP P29117 PPIF_RAT 43 206 DBREF 4TOT C 2 165 UNP P29117 PPIF_RAT 43 206 DBREF 4TOT D 2 165 UNP P29117 PPIF_RAT 43 206 DBREF 4TOT E 1 11 PDB 4TOT 4TOT 1 11 DBREF 4TOT F 1 11 PDB 4TOT 4TOT 1 11 DBREF 4TOT G 1 11 PDB 4TOT 4TOT 1 11 DBREF 4TOT H 1 11 PDB 4TOT 4TOT 1 11 SEQADV 4TOT ALA A 1 UNP P29117 EXPRESSION TAG SEQADV 4TOT ILE A 133 UNP P29117 LYS 174 ENGINEERED MUTATION SEQADV 4TOT ALA B 1 UNP P29117 EXPRESSION TAG SEQADV 4TOT ILE B 133 UNP P29117 LYS 174 ENGINEERED MUTATION SEQADV 4TOT ALA C 1 UNP P29117 EXPRESSION TAG SEQADV 4TOT ILE C 133 UNP P29117 LYS 174 ENGINEERED MUTATION SEQADV 4TOT ALA D 1 UNP P29117 EXPRESSION TAG SEQADV 4TOT ILE D 133 UNP P29117 LYS 174 ENGINEERED MUTATION SEQRES 1 A 165 ALA GLN ASN PRO LEU VAL TYR LEU ASP VAL GLY ALA ASP SEQRES 2 A 165 GLY GLN PRO LEU GLY ARG VAL VAL LEU GLU LEU LYS ALA SEQRES 3 A 165 ASP VAL VAL PRO LYS THR ALA GLU ASN PHE ARG ALA LEU SEQRES 4 A 165 CYS THR GLY GLU LYS GLY PHE GLY TYR LYS GLY SER THR SEQRES 5 A 165 PHE HIS ARG VAL ILE PRO ALA PHE MET CYS GLN ALA GLY SEQRES 6 A 165 ASP PHE THR ASN HIS ASN GLY THR GLY GLY LYS SER ILE SEQRES 7 A 165 TYR GLY SER ARG PHE PRO ASP GLU ASN PHE THR LEU LYS SEQRES 8 A 165 HIS VAL GLY PRO GLY VAL LEU SER MET ALA ASN ALA GLY SEQRES 9 A 165 PRO ASN THR ASN GLY SER GLN PHE PHE ILE CYS THR ILE SEQRES 10 A 165 LYS THR ASP TRP LEU ASP GLY LYS HIS VAL VAL PHE GLY SEQRES 11 A 165 HIS VAL ILE GLU GLY MET ASP VAL VAL LYS LYS ILE GLU SEQRES 12 A 165 SER PHE GLY SER LYS SER GLY LYS THR SER LYS LYS ILE SEQRES 13 A 165 VAL ILE THR ASP CYS GLY GLN LEU SER SEQRES 1 B 165 ALA GLN ASN PRO LEU VAL TYR LEU ASP VAL GLY ALA ASP SEQRES 2 B 165 GLY GLN PRO LEU GLY ARG VAL VAL LEU GLU LEU LYS ALA SEQRES 3 B 165 ASP VAL VAL PRO LYS THR ALA GLU ASN PHE ARG ALA LEU SEQRES 4 B 165 CYS THR GLY GLU LYS GLY PHE GLY TYR LYS GLY SER THR SEQRES 5 B 165 PHE HIS ARG VAL ILE PRO ALA PHE MET CYS GLN ALA GLY SEQRES 6 B 165 ASP PHE THR ASN HIS ASN GLY THR GLY GLY LYS SER ILE SEQRES 7 B 165 TYR GLY SER ARG PHE PRO ASP GLU ASN PHE THR LEU LYS SEQRES 8 B 165 HIS VAL GLY PRO GLY VAL LEU SER MET ALA ASN ALA GLY SEQRES 9 B 165 PRO ASN THR ASN GLY SER GLN PHE PHE ILE CYS THR ILE SEQRES 10 B 165 LYS THR ASP TRP LEU ASP GLY LYS HIS VAL VAL PHE GLY SEQRES 11 B 165 HIS VAL ILE GLU GLY MET ASP VAL VAL LYS LYS ILE GLU SEQRES 12 B 165 SER PHE GLY SER LYS SER GLY LYS THR SER LYS LYS ILE SEQRES 13 B 165 VAL ILE THR ASP CYS GLY GLN LEU SER SEQRES 1 C 165 ALA GLN ASN PRO LEU VAL TYR LEU ASP VAL GLY ALA ASP SEQRES 2 C 165 GLY GLN PRO LEU GLY ARG VAL VAL LEU GLU LEU LYS ALA SEQRES 3 C 165 ASP VAL VAL PRO LYS THR ALA GLU ASN PHE ARG ALA LEU SEQRES 4 C 165 CYS THR GLY GLU LYS GLY PHE GLY TYR LYS GLY SER THR SEQRES 5 C 165 PHE HIS ARG VAL ILE PRO ALA PHE MET CYS GLN ALA GLY SEQRES 6 C 165 ASP PHE THR ASN HIS ASN GLY THR GLY GLY LYS SER ILE SEQRES 7 C 165 TYR GLY SER ARG PHE PRO ASP GLU ASN PHE THR LEU LYS SEQRES 8 C 165 HIS VAL GLY PRO GLY VAL LEU SER MET ALA ASN ALA GLY SEQRES 9 C 165 PRO ASN THR ASN GLY SER GLN PHE PHE ILE CYS THR ILE SEQRES 10 C 165 LYS THR ASP TRP LEU ASP GLY LYS HIS VAL VAL PHE GLY SEQRES 11 C 165 HIS VAL ILE GLU GLY MET ASP VAL VAL LYS LYS ILE GLU SEQRES 12 C 165 SER PHE GLY SER LYS SER GLY LYS THR SER LYS LYS ILE SEQRES 13 C 165 VAL ILE THR ASP CYS GLY GLN LEU SER SEQRES 1 D 165 ALA GLN ASN PRO LEU VAL TYR LEU ASP VAL GLY ALA ASP SEQRES 2 D 165 GLY GLN PRO LEU GLY ARG VAL VAL LEU GLU LEU LYS ALA SEQRES 3 D 165 ASP VAL VAL PRO LYS THR ALA GLU ASN PHE ARG ALA LEU SEQRES 4 D 165 CYS THR GLY GLU LYS GLY PHE GLY TYR LYS GLY SER THR SEQRES 5 D 165 PHE HIS ARG VAL ILE PRO ALA PHE MET CYS GLN ALA GLY SEQRES 6 D 165 ASP PHE THR ASN HIS ASN GLY THR GLY GLY LYS SER ILE SEQRES 7 D 165 TYR GLY SER ARG PHE PRO ASP GLU ASN PHE THR LEU LYS SEQRES 8 D 165 HIS VAL GLY PRO GLY VAL LEU SER MET ALA ASN ALA GLY SEQRES 9 D 165 PRO ASN THR ASN GLY SER GLN PHE PHE ILE CYS THR ILE SEQRES 10 D 165 LYS THR ASP TRP LEU ASP GLY LYS HIS VAL VAL PHE GLY SEQRES 11 D 165 HIS VAL ILE GLU GLY MET ASP VAL VAL LYS LYS ILE GLU SEQRES 12 D 165 SER PHE GLY SER LYS SER GLY LYS THR SER LYS LYS ILE SEQRES 13 D 165 VAL ILE THR ASP CYS GLY GLN LEU SER SEQRES 1 E 11 DAL MLE MLE MVA BMT ABA 33X 34E VAL MLE ALA SEQRES 1 F 11 DAL MLE MLE MVA BMT ABA 33X 34E VAL MLE ALA SEQRES 1 G 11 DAL MLE MLE MVA BMT ABA 33X 34E VAL MLE ALA SEQRES 1 H 11 DAL MLE MLE MVA BMT ABA 33X 34E VAL MLE ALA HET DAL E 1 10 HET MLE E 2 22 HET MLE E 3 22 HET MVA E 4 19 HET BMT E 5 30 HET ABA E 6 13 HET 33X E 7 13 HET 34E E 8 43 HET MLE E 10 22 HET DAL F 1 10 HET MLE F 2 22 HET MLE F 3 22 HET MVA F 4 19 HET BMT F 5 30 HET ABA F 6 13 HET 33X F 7 13 HET 34E F 8 43 HET MLE F 10 22 HET DAL G 1 10 HET MLE G 2 22 HET MLE G 3 22 HET MVA G 4 19 HET BMT G 5 30 HET ABA G 6 13 HET 33X G 7 13 HET 34E G 8 43 HET MLE G 10 22 HET DAL H 1 10 HET MLE H 2 22 HET MLE H 3 22 HET MVA H 4 19 HET BMT H 5 30 HET ABA H 6 13 HET 33X H 7 13 HET 34E H 8 43 HET MLE H 10 22 HET P6G A 201 45 HET SO4 A 202 5 HET P6G B 201 45 HET SO4 B 202 5 HET P6G C 201 45 HET P6G D 201 45 HETNAM DAL D-ALANINE HETNAM MLE N-METHYLLEUCINE HETNAM MVA N-METHYLVALINE HETNAM BMT 4-METHYL-4-[(E)-2-BUTENYL]-4,N-METHYL-THREONINE HETNAM ABA ALPHA-AMINOBUTYRIC ACID HETNAM 33X N-METHYL-D-ALANINE HETNAM 34E (3R)-4-[4-(2-METHOXYETHYL)PIPERAZIN-1-YL]-N-METHYL-L- HETNAM 2 34E VALINE HETNAM P6G HEXAETHYLENE GLYCOL HETNAM SO4 SULFATE ION HETSYN P6G POLYETHYLENE GLYCOL PEG400 FORMUL 5 DAL 4(C3 H7 N O2) FORMUL 5 MLE 12(C7 H15 N O2) FORMUL 5 MVA 4(C6 H13 N O2) FORMUL 5 BMT 4(C10 H19 N O3) FORMUL 5 ABA 4(C4 H9 N O2) FORMUL 5 33X 4(C4 H9 N O2) FORMUL 5 34E 4(C13 H27 N3 O3) FORMUL 9 P6G 4(C12 H26 O7) FORMUL 10 SO4 2(O4 S 2-) FORMUL 15 HOH *298(H2 O) HELIX 1 AA1 VAL A 29 GLY A 42 1 14 HELIX 2 AA2 THR A 119 ASP A 123 5 5 HELIX 3 AA3 GLY A 135 PHE A 145 1 11 HELIX 4 AA4 VAL B 29 GLY B 42 1 14 HELIX 5 AA5 THR B 119 ASP B 123 5 5 HELIX 6 AA6 GLY B 135 PHE B 145 1 11 HELIX 7 AA7 VAL C 29 GLY C 42 1 14 HELIX 8 AA8 THR C 119 ASP C 123 5 5 HELIX 9 AA9 GLY C 135 PHE C 145 1 11 HELIX 10 AB1 VAL D 29 GLY D 42 1 14 HELIX 11 AB2 THR D 119 ASP D 123 5 5 HELIX 12 AB3 GLY D 135 PHE D 145 1 11 SHEET 1 AA1 8 ARG A 55 ILE A 57 0 SHEET 2 AA1 8 MET A 61 ALA A 64 -1 O GLN A 63 N ARG A 55 SHEET 3 AA1 8 PHE A 112 CYS A 115 -1 O ILE A 114 N CYS A 62 SHEET 4 AA1 8 VAL A 97 MET A 100 -1 N VAL A 97 O CYS A 115 SHEET 5 AA1 8 VAL A 128 GLU A 134 -1 O GLY A 130 N LEU A 98 SHEET 6 AA1 8 GLN A 15 LEU A 24 -1 N VAL A 21 O GLU A 134 SHEET 7 AA1 8 LEU A 5 ALA A 12 -1 N VAL A 10 O LEU A 17 SHEET 8 AA1 8 ILE A 156 SER A 165 -1 O ASP A 160 N ASP A 9 SHEET 1 AA2 8 PHE B 53 ILE B 57 0 SHEET 2 AA2 8 MET B 61 ALA B 64 -1 O GLN B 63 N ARG B 55 SHEET 3 AA2 8 PHE B 112 CYS B 115 -1 O PHE B 112 N ALA B 64 SHEET 4 AA2 8 VAL B 97 MET B 100 -1 N VAL B 97 O CYS B 115 SHEET 5 AA2 8 VAL B 128 GLU B 134 -1 O GLY B 130 N LEU B 98 SHEET 6 AA2 8 GLN B 15 LEU B 24 -1 N VAL B 21 O GLU B 134 SHEET 7 AA2 8 LEU B 5 ALA B 12 -1 N VAL B 10 O LEU B 17 SHEET 8 AA2 8 ILE B 156 SER B 165 -1 O ASP B 160 N ASP B 9 SHEET 1 AA3 8 ARG C 55 ILE C 57 0 SHEET 2 AA3 8 MET C 61 ALA C 64 -1 O GLN C 63 N ARG C 55 SHEET 3 AA3 8 PHE C 112 CYS C 115 -1 O ILE C 114 N CYS C 62 SHEET 4 AA3 8 VAL C 97 MET C 100 -1 N SER C 99 O PHE C 113 SHEET 5 AA3 8 VAL C 128 GLU C 134 -1 O GLY C 130 N LEU C 98 SHEET 6 AA3 8 GLN C 15 LEU C 24 -1 N VAL C 21 O GLU C 134 SHEET 7 AA3 8 LEU C 5 ALA C 12 -1 N VAL C 10 O LEU C 17 SHEET 8 AA3 8 ILE C 156 SER C 165 -1 O ASP C 160 N ASP C 9 SHEET 1 AA4 8 ARG D 55 ILE D 57 0 SHEET 2 AA4 8 MET D 61 ALA D 64 -1 O GLN D 63 N ARG D 55 SHEET 3 AA4 8 PHE D 112 CYS D 115 -1 O PHE D 112 N ALA D 64 SHEET 4 AA4 8 VAL D 97 MET D 100 -1 N SER D 99 O PHE D 113 SHEET 5 AA4 8 VAL D 128 GLU D 134 -1 O GLY D 130 N LEU D 98 SHEET 6 AA4 8 GLN D 15 LEU D 24 -1 N VAL D 21 O GLU D 134 SHEET 7 AA4 8 LEU D 5 ALA D 12 -1 N ALA D 12 O GLN D 15 SHEET 8 AA4 8 ILE D 156 SER D 165 -1 O ASP D 160 N ASP D 9 LINK C DAL E 1 N MLE E 2 1555 1555 1.37 LINK N DAL E 1 C ALA E 11 1555 1555 1.33 LINK C MLE E 2 N MLE E 3 1555 1555 1.37 LINK C MLE E 3 N MVA E 4 1555 1555 1.37 LINK C MVA E 4 N BMT E 5 1555 1555 1.38 LINK C BMT E 5 N ABA E 6 1555 1555 1.36 LINK C ABA E 6 N 33X E 7 1555 1555 1.37 LINK C 33X E 7 N 34E E 8 1555 1555 1.37 LINK C 34E E 8 N VAL E 9 1555 1555 1.34 LINK C VAL E 9 N MLE E 10 1555 1555 1.38 LINK C MLE E 10 N ALA E 11 1555 1555 1.33 LINK C DAL F 1 N MLE F 2 1555 1555 1.36 LINK N DAL F 1 C ALA F 11 1555 1555 1.33 LINK C MLE F 2 N MLE F 3 1555 1555 1.38 LINK C MLE F 3 N MVA F 4 1555 1555 1.37 LINK C MVA F 4 N BMT F 5 1555 1555 1.38 LINK C BMT F 5 N ABA F 6 1555 1555 1.35 LINK C ABA F 6 N 33X F 7 1555 1555 1.37 LINK C 33X F 7 N 34E F 8 1555 1555 1.37 LINK C 34E F 8 N VAL F 9 1555 1555 1.34 LINK C VAL F 9 N MLE F 10 1555 1555 1.38 LINK C MLE F 10 N ALA F 11 1555 1555 1.33 LINK C DAL G 1 N MLE G 2 1555 1555 1.36 LINK N DAL G 1 C ALA G 11 1555 1555 1.34 LINK C MLE G 2 N MLE G 3 1555 1555 1.37 LINK C MLE G 3 N MVA G 4 1555 1555 1.37 LINK C MVA G 4 N BMT G 5 1555 1555 1.38 LINK C BMT G 5 N ABA G 6 1555 1555 1.34 LINK C ABA G 6 N 33X G 7 1555 1555 1.37 LINK C 33X G 7 N 34E G 8 1555 1555 1.37 LINK C 34E G 8 N VAL G 9 1555 1555 1.34 LINK C VAL G 9 N MLE G 10 1555 1555 1.37 LINK C MLE G 10 N ALA G 11 1555 1555 1.34 LINK C DAL H 1 N MLE H 2 1555 1555 1.37 LINK N DAL H 1 C ALA H 11 1555 1555 1.34 LINK C MLE H 2 N MLE H 3 1555 1555 1.38 LINK C MLE H 3 N MVA H 4 1555 1555 1.37 LINK C MVA H 4 N BMT H 5 1555 1555 1.37 LINK C BMT H 5 N ABA H 6 1555 1555 1.35 LINK C ABA H 6 N 33X H 7 1555 1555 1.38 LINK C 33X H 7 N 34E H 8 1555 1555 1.37 LINK C 34E H 8 N VAL H 9 1555 1555 1.34 LINK C VAL H 9 N MLE H 10 1555 1555 1.37 LINK C MLE H 10 N ALA H 11 1555 1555 1.35 SITE 1 AC1 7 VAL A 93 GLY A 94 PRO A 95 HIS A 131 SITE 2 AC1 7 LYS B 44 PHE B 46 ILE B 78 SITE 1 AC2 2 LYS A 148 LYS C 148 SITE 1 AC3 8 PHE A 46 ILE A 78 VAL B 93 GLY B 94 SITE 2 AC3 8 PRO B 95 HIS B 131 HOH B 306 HOH B 375 SITE 1 AC4 3 SER B 147 LYS B 148 HOH B 318 SITE 1 AC5 8 VAL C 93 GLY C 94 PRO C 95 HIS C 131 SITE 2 AC5 8 PHE D 46 SER D 77 ILE D 78 GLY D 80 SITE 1 AC6 6 PHE C 46 ILE C 78 VAL D 93 GLY D 94 SITE 2 AC6 6 PRO D 95 HIS D 131 SITE 1 AC7 22 ARG A 55 PHE A 60 MET A 61 GLN A 63 SITE 2 AC7 22 GLY A 72 THR A 73 ALA A 101 ASN A 102 SITE 3 AC7 22 ALA A 103 GLN A 111 PHE A 113 TRP A 121 SITE 4 AC7 22 HIS A 126 ALA C 59 ILE C 117 TRP C 121 SITE 5 AC7 22 HOH E 102 HOH E 103 HOH E 104 HOH E 105 SITE 6 AC7 22 HOH E 106 MLE G 2 SITE 1 AC8 19 ARG B 55 PHE B 60 GLN B 63 GLY B 72 SITE 2 AC8 19 THR B 73 ALA B 101 ASN B 102 ALA B 103 SITE 3 AC8 19 GLN B 111 PHE B 113 TRP B 121 HIS B 126 SITE 4 AC8 19 ALA D 59 ILE D 117 TRP D 121 HOH F 101 SITE 5 AC8 19 HOH F 102 HOH F 104 MLE H 2 SITE 1 AC9 21 PRO A 58 ALA A 59 ARG C 55 PHE C 60 SITE 2 AC9 21 MET C 61 GLN C 63 GLY C 72 THR C 73 SITE 3 AC9 21 ALA C 101 ASN C 102 ALA C 103 GLN C 111 SITE 4 AC9 21 PHE C 113 TRP C 121 LEU C 122 HIS C 126 SITE 5 AC9 21 SER D 144 SER D 153 LYS D 154 DAL E 1 SITE 6 AC9 21 HOH G 103 SITE 1 AD1 23 PRO B 58 ALA B 59 PHE C 145 LYS C 154 SITE 2 AD1 23 ARG D 55 PHE D 60 MET D 61 GLN D 63 SITE 3 AD1 23 GLY D 72 THR D 73 ALA D 101 ASN D 102 SITE 4 AD1 23 ALA D 103 GLN D 111 PHE D 113 TRP D 121 SITE 5 AD1 23 HIS D 126 DAL F 1 MLE F 2 HOH H 101 SITE 6 AD1 23 HOH H 102 HOH H 103 HOH H 105 CRYST1 50.197 57.286 75.274 89.95 83.81 89.86 P 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019922 -0.000049 -0.002161 0.00000 SCALE2 0.000000 0.017456 -0.000011 0.00000 SCALE3 0.000000 0.000000 0.013363 0.00000